Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback